Zydus Executive and Leadership Team

Sanjeev Kumar, the President at Zydus, directs critical operational functions integral to the company's global pharmaceutical manufacturing and distribution network. Overseeing key strategic initiatives, Kumar ensures alignment with Zydus's mission to provide comprehensive pharmaceutical products and services across regulated and emerging markets. This leadership position involves driving efficiency within manufacturing sites located across India, the United States, and Brazil. By optimizing production workflows and resource allocation, Kumar directly supports the company's extensive research and development capabilities. The focus remains on enhancing the delivery of Zydus's diverse portfolio, ensuring robust supply chains that reach markets in North America, Europe, Latin America, and South Africa. Sanjeev Kumar's oversight is crucial for maintaining Zydus's significant global footprint and market presence.

Mangesh Vaze, the President, Api Business at Zydus, spearheads the strategic direction and operational execution of the Active Pharmaceutical Ingredients (API) division. Vaze's leadership ensures the robust development, manufacturing, and global distribution of APIs, which form the core components of Zydus's pharmaceutical products. This role involves close collaboration with research facilities to advance API innovation and scale production to meet international demand. Mangesh Vaze oversees the integration of advanced manufacturing technologies within Zydus's facilities in India, the United States, and Brazil, ensuring compliance with stringent regulatory standards across key markets like the United States and Europe. The objective is to strengthen Zydus's competitive edge by providing high-quality APIs that support the company's comprehensive product portfolio and extensive R&D capabilities. Vaze's strategic focus drives the API business's contribution to Zydus's global market impact.

Nitin Parekh, the President (Special Projects) at Zydus, drives the strategic planning and execution of critical, high-impact initiatives that advance the company's long-term objectives. Parekh's mandate involves identifying and developing new opportunities, optimizing existing operations, and ensuring the successful implementation of complex projects across Zydus's global network. This leadership function requires a deep understanding of the pharmaceutical industry landscape, market dynamics, and emerging trends. Nitin Parekh collaborates closely with various departments to foster innovation and enhance the company's competitive positioning in regulated markets such as the United States and Europe, as well as in emerging economies. The focus is on leveraging Zydus's extensive R&D capabilities and manufacturing infrastructure in India, the United States, and Brazil to achieve strategic growth and operational excellence. Parekh's role is pivotal in navigating Zydus's expansion and solidifying its significant global footprint.

Kapil Maithal, the President at Zydus, directs key operational segments that contribute to the company's expansive pharmaceutical manufacturing and distribution efforts. Maithal's responsibilities encompass overseeing critical processes that ensure the efficient production and timely delivery of Zydus's diverse product portfolio across its global network. This involves managing complex supply chains and optimizing manufacturing operations within facilities located in India, the United States, and Brazil. Kapil Maithal works to enhance the integration of research and development findings into scalable production, supporting Zydus's commitment to innovation. The strategic aim is to bolster Zydus's presence in regulated markets, including the United States and Europe, and to effectively serve numerous emerging markets worldwide. Maithal's leadership is essential for maintaining operational integrity and driving the company's growth trajectory.

Kacharu Toshniwal, the President at Zydus, oversees critical aspects of the company's operational framework, ensuring the seamless execution of its global pharmaceutical development and manufacturing strategies. Toshniwal's leadership focuses on optimizing production processes and resource management across Zydus's extensive network of manufacturing sites in India, the United States, and Brazil. This role is vital for maintaining the high standards required for pharmaceutical products distributed in regulated markets like the United States and Europe, as well as in emerging economies. Kacharu Toshniwal drives initiatives that enhance operational efficiency and support the company's robust research and development capabilities. The objective is to ensure Zydus consistently delivers its comprehensive portfolio of pharmaceutical products and services, reinforcing its significant global footprint and market leadership. Toshniwal's contributions are fundamental to Zydus's ongoing success.

Rishikesh Raval, the Group President, Human Resources & Corporate Communications at Zydus, shapes and directs the company's human capital strategy and external messaging. Raval's leadership ensures that Zydus cultivates a high-performing workforce and maintains a strong, consistent corporate identity across its global operations. This involves developing and implementing comprehensive HR policies that support employee growth and engagement within Zydus's manufacturing and research facilities in India, the United States, and Brazil. Rishikesh Raval also oversees strategic communication efforts, reinforcing Zydus's mission and market position to stakeholders worldwide, including in regulated markets like the United States and Europe. By fostering a positive organizational culture and managing corporate reputation, Raval directly contributes to Zydus's ability to attract and retain top talent, essential for its extensive R&D and global distribution efforts. Raval's role is integral to Zydus's sustained success and market impact.

Harish Sadana, the President Corporate Matters at Zydus, manages and directs critical corporate functions essential for the company's strategic operations and regulatory compliance. Sadana's oversight ensures that Zydus adheres to all corporate governance standards and legal requirements across its international operations, including manufacturing sites in India, the United States, and Brazil. This leadership position involves navigating complex legal frameworks and ensuring robust corporate policies are in place to support the company's global pharmaceutical development and distribution. Harish Sadana plays a key part in maintaining Zydus's strong presence in regulated markets, such as the United States and Europe, while also facilitating expansion into emerging markets. By ensuring operational integrity and compliance, Sadana directly supports Zydus's extensive research and development initiatives and its comprehensive product portfolio. Sadana's focus is vital for Zydus's sustained global market engagement.

Dr.Amrut Naik, the President at Zydus, leads critical initiatives focused on advancing the company's pharmaceutical research and development pipeline. Naik's expertise drives innovation in drug discovery and development, ensuring Zydus remains at the forefront of medical advancements. This role involves overseeing research facilities and fostering a culture of scientific excellence to create a comprehensive portfolio of pharmaceutical products. Dr.Amrut Naik collaborates closely with manufacturing teams across India, the United States, and Brazil to translate research breakthroughs into scalable production. The objective is to enhance Zydus's offerings for regulated markets, including the United States and Europe, and to address unmet medical needs in emerging markets worldwide. Naik's strategic direction is fundamental to Zydus's commitment to improving global health outcomes and reinforcing its significant global footprint. Dr.Amrut Naik's leadership propels Zydus's mission forward.